I
Immunocore Holdings plc (IMCR)
NMS – Real Time Price. Currency in USD
29.30
+0.45 (1.56%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
29.30
+0.45 (1.56%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.18 | 6.05 | 10 | |
| Quick ratio | 4.15 | 5.63 | 10 | |
| Debt to Equity | 1.11 | 0.30 | 6.0 | |
| Debt to Assets | 0.41 | 1.04 | 6.0 | |
| Interest coverage | 2.39 | -16.91 | 6.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 177M | 250M | 310M | 401M | 413M |
| Gross Profit | 169M | 245M | 303M | 393M | 405M |
| Operating Income | -64M | -60M | -70M | -45M | -35M |
| Net Income | -51M | -56M | -51M | -36M | -28M |
| EBITDA | -56M | -56M | -66M | -42M | -31M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 12.73 | 91.31 | 9.0 |
| Next quarter | 9.75 | N/A | 3.5 |
| Current year | 12.08 | 102.92 | 8.5 |
| Next year | 8.59 | -3197.63 | 3.5 |
| Weighted average score | 6.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 2.08 | 143.14 | 141.67 | 56.43 | 8.3 |
| Y/Y | 13.01 | 156.81 | 150 | -11392.02 | 7.3 |
| 3y average | 31.52 | 9.66 | 12.15 | 286.34 | 8.3 |
| 5y average | 94.89 | 2.11 | 24.52 | 172.3 | 8.3 |
| Weighted average score | 8.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $452.7M significantly exceed its total debt $435.7M, ensuring strong financial flexibility
Total current assets $1.0B exceed Total current liabilities $240.1M, highlighting excellent liquidity
Debt-to-equity ratio (1.1) is near the industry average, reflecting balanced leverage
Interest coverage ratio (2x) is sufficient but not particularly strong
Negative free cash flow -$15.5M limits the company's ability to reinvest or pay down debt